MMA in the news · Mind Medicine Australia
Mind Medicine Australia logo Menu

MMA in the news

Doubt it not, MDMA is a medicine

Mind Medicine Australia, Drug Science UK and Parea, June 21, 2024

The recent rejection of MDMA-assisted therapy for PTSD by the FDA Psychopharmacologic Drugs Advisory Committee (AdCom) was surprising to many working in the field of mental illness.

Adam’s son died in the Hunter Valley bus crash. In a NSW first, he’ll try MDMA to ease his anguish

The Sydney Morning Herald, June 3, 2024

Associate professor Ranil Gunewardene, who is a psychiatrist and director of Evolution: Medicine Enhanced Therapy, has been approved by the TGA’s authorised prescriber scheme to run the first treatment service and research study in NSW.

Read the full PDF article here.

Optimi Health gets psychedelics import permit for Mind Medicine Australia shipment

Mugglehead Magazine, May 31, 2024

British Columbia’s psychedelics and natural health products company Optimi Health Corp. (CSE: OPTI) has been making significant progress toward achieving its international distribution goals.

This week, the company obtained a permit to send MDMA and psilocybin capsules to the non-profit charity organization Mind Medicine Australia.

Tania de Jong AM Interview about Psychedelic-Assisted Therapies on 6PR

6PR, May 30, 2024

Tania de Jong AM, Executive Director of Mind Medicine Australia, is interviewed about psychedelic-assisted therapies in Australia.

Optimi Health Secures Import Permit from Mind Medicine Australia for MDMA and Psilocybin Capsules

Globe News Wire, May 29, 2024

Company preparing to export 160 doses of MDMA and psilocybin under Australia’s Authorized Prescriber Scheme.

Psychedelics import deal struck as activists move ahead of regulators

The Australian, May 29, 2024

A deal that paves the way for Australia’s biggest importation of psychedelic medicines has been struck by a charity pushing the therapy, with a Canadian manufacturer pledging to “provide financial assistance to marginalised Australians” to help them access MDMA and psilocybin.

Read the full PDF article.

Is it now time to prepare psychiatry for a psychedelic future?

British Journal of Psychiatry, May 20, 2024

“Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.”

Psychedelic-Assisted Therapy Treating Trauma

Australian Jewish News, May 17, 2024

An Australian doctor recently became the first in the world to treat a patient with a controlled dose of MDMA, putting Australia at the forefront of the emerging field of psychedelics.

MDMA Therapy In Australia: Making History One Prescription at a Time

Psychedelics.com, March 25, 2024

On a remarkable day in January 2024, the field of mental health witnessed a history-making moment: the first prescription of MDMA for a patient with chronic, treatment-resistant PTSD outside of a trial setting.

NSW Mental Health Minister Rose Jackson acknowledges calls for NSW to expand psilocybin, MDMA treatments

The Australian, March 14, 2024

NSW Mental Health Minister Rose Jackson has conceded more needs to be done to allow people suffering from severe mental health conditions to access emerging therapies such as MDMA and psilocybin.

Read the full PDF article here.

The Healing Powers of Magic Mushrooms and MDMA: Psychedelic-Assisted Therapies for the Treatment of PTSD and Depression

All About You Podcast, March 3, 2024

On this episode of the All About You Podcast, Tania de Jong AM shares about our work with Mind Medicine Australia and the healing powers of these treatments.

Aussie doctor becomes first to prescribe medicinal MDMA

9 News Australia, February 11, 2024

An Australian doctor has become the talk of the medical world after becoming the first to prescribe MDMA for the treatment of post-traumatic stress disorder.

An Australian doctor has just made global history. This is what happened

The Age, February 7, 2024

A single pill administered in a borrowed medical clinic has become the talk of mental health doctors around the world. Ted Cassidy’s patient took a capsule containing a drug known by recreational users as ecstasy, but which was approved for prescription in its pure form by Australian regulators last year – for the first time ever, anywhere – to assist therapy for sufferers of complex post-traumatic stress disorder. It was one of the first dosages in Australia, alongside another given by Victorian psychiatrist Eli Kotler the same week.

Incannex and partner Clarion open Australia’s first psychedelic therapy clinic in Melbourne

Mugglehead Magazine, February 4, 2024

Mind Medicine Australia legally dosed the first patients outside of clinical trials in over 50 years last month

Caution over psychedelic meds in new approach to trauma

Yahoo! News, February 3, 2024

Melbourne psychiatrist and MMA Board Member, Dr Eli Kotler is among a handful of Australian doctors able to prescribe psychedelic medication in limited circumstances.

Tania de Jong AM on Speak with Courage

Speak with Courage! Podcast, January 31, 2024

Our Executive Director, Tania de Jong AM, discusses our work with Mind Medicine Australia.

The first patient treated in 50 years interviewed by Phillip Adams

ABC Radio - Light Night Live with Phillip Adams, January 30, 2024

Phillip Adams interviews Dr Eli Kotler and the first patient treated with MDMA therapy after 50 years in Australia.

The interview starts at 13 minutes.

Group approach may increase accessibility to psychedelic therapy

ANU College of Health & Medicine, January 23, 2024

Evidence continues to build for the use of psychedelic agents, such as psilocybin and MDMA, to treat depression, anxiety, trauma and OCD. Each therapy session takes six or more hours. This approach can create cost barriers to accessing treatment. In a bid to increase accessibility, a new study by the Australian National University (ANU) School of Medicine and Psychology will look into the viability of the application of psychedelics in a group setting. The study will run over a three-year period with funding by Mind Medicine Australia.

Melbourne mental health patients receive world-first treatment

9 News Australia, January 21, 2024

In what’s being hailed as a world first, mental health patients in Melbourne have been treated with magic mushrooms for psychedelic drug therapy

The ancient remedy achieving a year’s worth of therapy in a day

7 News Australia, January 20, 2024

Melbourne has become the first place in the world where magic mushrooms and MDMA can be prescribed for severe mental health conditions. The first patients began the treatment this week and their doctors have been shocked by the results.

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×